Correspondence 0001193125-24-004455 from NEVRO CORP (NVRO) (CIK 0001444380)
NEVRO CORP (NVRO) (CIK 0001444380)
Date: Jan. 8, 2024 · CIK: 0001444380 · Accession: 0001193125-24-004455
AI Filing Summary & Sentiment
File numbers found in text: 333-276306
Letter
Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services Attention: Robert Augustin Re: Nevro Corp. Registration Statement on Form S-3 Filed December 29, 2023 Registration No. 333-276306
Dear Mr. Augustin:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Nevro Corp. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated by the Securities and Exchange Commission to 4:30 p.m. Washington D.C. time on January 10, 2024, or as soon as practicable thereafter, or at such later time as the Company or its counsel may request via telephone call to the staff. Please contact Daniel Rees of Latham & Watkins LLP, counsel to the Company, at (714) 755-2244, or in his absence, Phillip S. Stoup of Latham & Watkins LLP at (415) 395-8216, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter.
Thank you for your assistance in this matter.
* * * *
Sincerely,
Nevro Corp.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Nevro Corp. 1800 Bridge Parkway Redwood City, CA 94065 January 8, 2024 Via EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, D.C. 20549 Attention: Robert Augustin Re: Nevro Corp. Registration Statement on Form S-3 Filed December 29, 2023 Registration No. 333-276306 Dear Mr. Augustin: Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Nevro Corp. (the “Company”) hereby respectfully requests that the effective date of the above-referenced Registration Statement be accelerated by the Securities and Exchange Commission to 4:30 p.m. Washington D.C. time on January 10, 2024, or as soon as practicable thereafter, or at such later time as the Company or its counsel may request via telephone call to the staff. Please contact Daniel Rees of Latham & Watkins LLP, counsel to the Company, at (714) 755-2244, or in his absence, Phillip S. Stoup of Latham & Watkins LLP at (415) 395-8216, to provide notice of effectiveness, or if you have any other questions or concerns regarding this matter. Thank you for your assistance in this matter. * * * * Sincerely, Nevro Corp. By: /s/ Kevin Thornal Kevin Thornal Chief Executive Officer and President CC: Kashif Rashid, Senior Vice President and General Counsel Daniel Rees, Latham & Watkins LLP Phillip S. Stoup, Latham & Watkins LLP